On the relationship between neurocysticercosis and mesial temporal lobe epilepsy associated with hippocampal sclerosis: Coincidence or a pathogenic relationship?

Pathogens and Global Health

Volumn 106, Issue 5, 2012, Pages 280-285

  Bianchin, Marino Muxfeldt ^a   Velasco, Tonicarlo Rodrigues ^b   dos Santos, Antonio Carlos ^b   Sakamoto, Américo Ceiki ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Epilepsy; Hippocampal sclerosis; Initial precipitating injury; Neurocysticercosis; Temporal lobe epilepsy

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAPHY; HEALTH CARE SYSTEM; HIPPOCAMPAL SCLEROSIS; HUMAN; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREVALENCE; TEMPORAL LOBE EPILEPSY; TEMPORAL LOBECTOMY;

EPILEPSY, TEMPORAL LOBE; HUMANS; NEUROCYSTICERCOSIS; SCLEROSIS;

EID: 84874829940     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773212Y.0000000027     Document Type: Article

References (51)

1. Hause WA. Incidence and prevalence. In: Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia, PA: Lippincott-Raven; 1998. p. 47-57.
2. Pal DK, Carpio A, Sander JW. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry. 2000;68(2):137-143.
3. Sander JW, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry. 1996;61(5):433-443.
4. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol. 2003;16(2):165-170.
5. Engel J Jr. Mesial temporal lobe epilepsy: what have we learned. Neuroscientist. 2001;7(4):340-352.
6. Wieser HG. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia. 2004;45(6):695-714.
7. Mathern GW, Pretorius JK, Babb TL. Influence of the type of initial precipitating injury and at what age it occurs on course and outcome in patients with temporal lobe seizures. J Neurosurg. 1995;82(2):220-227.
8. Mathern GW, Babb TL, Vickrey BG, Melendez M, Pretorius JK. The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain. 1995;118(Pt 1):105-118.
9. Mathern GW, Adelson PD, Cahan LD, Leite JP. Hippocampal neuron damage in human epilepsy: Meyer's hypothesis revisited. Prog Brain Res. 2002;135:237-251.
10. Lewis DV. Losing neurons: selective vulnerability and mesial temporal sclerosis. Epilepsia. 2005;46(Suppl 7):39-44.
11. Lévesque MF, Nakasato N, Vinters HV, Babb TL. Surgical treatment of limbic epilepsy associated with extrahippocampal lesions: the problem of dual pathology. J Neurosurg. 1991;75(3):364-370.
12. Raymond AA, Fish DR, Stevens JM, Cook MJ, Sisodiya SM, Shorvon SD. Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy. Neurology. 1994;44(10):1841-1845.
13. Li LM, Cendes F, Andermann F, Watson C, Fish DR, Cook MJ, et al. Surgical outcome in patients with epilepsy and dual pathology. Brain. 1999;122(Pt 5):799-805.
14. Spencer S, Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol. 2008;7(6):525-537.
15. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis. 2002;2(12):751-762.
16. Garcia HH, Gonzalez AE, Evans CA, Gilman RH, Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet. 2003;362(9383):547-556.
17. Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol. 2011;7(10):584-594.
18. Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis. 2011;5(5):e1152.
19. Center for Disease Control and Prevention. Recomentadions of the International Task Force for Disease Eradication (ITFDE). MMWR Recomm Rep. 1993;42(RR-16):1-38.
20. Bern C, Garcia HH, Evans C, Gonzalez AE, Verastegui M, Tsang VC, et al. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis. 1999;29(5):1203-1209.
21. Rao KR, Lessing D. Neurocysticercosis in West London. Arch Dis Child. 2003;88(6):471.
22. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology. 2004;63(9):1559-1564.
23. White AC Jr. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu Rev Med. 2000;51:187-206.
24. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VC, et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis. 2002;8(6):608-613.
25. McCormick GF. Cysticercosis - review of 230 patients. Bull Clin Neurosci. 1985;50:76-101.
26. Shandera WX, White AC Jr, Chen JC, Diaz P, Armstrong R. Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine (Baltimore). 1994;73(1):37-52.
27. Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia. 1998;39(10):1025-1040.
28. Senanayake N, Roman GC. Epidemiology of epilepsy in developing countries. Bull World Health Organ. 1993;71(2):247-258.
29. Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VC, Schantz P. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci. 1996;142(1-2):1-6.
30. Forlenza OV, Filho AH, Nobrega JP, dos Ramos Machado L, de Barros NG, de Camargo CH, et al. Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurg Psychiatry. 1997;62(6):612-616.
31. Boppre MC, Wille PR, Guarnieri R, Rezek K, Carqueja C, Trevisol-Bittencourt PC, et al. Cognitive performance of patients with epilepsy and calcified neurocysticercotic lesions: a case-control study. Epilepsy Behav. 2001;2(6):558-562.
32. da Gama CN, Kobayashi E, Li LM, Cendes F. Hippocampal atrophy and neurocysticercosis calcifications. Seizure. 2005;14(2):85-88.
33. Kobayashi E, Guerreiro CA, Cendes F. Late onset temporal lobe epilepsy with MRI evidence of mesial temporal sclerosis following acute neurocysticercosis: case report. Arq Neuropsiquiatr. 2001;59(2-A):255-258.
34. Leite JP, Terra-Bustamante VC, Fernandes RM, Santos AC, Chimelli L, Sakamoto AC, et al. Calcified neurocysticercotic lesions and postsurgery seizure control in temporal lobe epilepsy. Neurology. 2000;55(10):1485-1491.
35. Wichert-Ana L, Velasco TR, Terra-Bustamante VC, Alexandre V Jr, Walz R, Bianchin MM, et al. Surgical treatment for mesial temporal lobe epilepsy in the presence of massive calcified neurocysticercosis. Arch Neurol. 2004;61(7):1117-1119.
36. Martinez JAG, Cukiert A, Marino R Jr, Yacubian EM. Cirurgia de epilepsia em pacientes com calcificações neurocisticercoticas. Braz J Epilepsy Clin Neurophysiol. 1995;1:131.
37. Jorge CL, Valerio RMF, Bueno JF, Guilhoto LMFF, Valente KDR, Yacubian EMT. Mesial temporal sclerosis: related or not to neurocysticercosis? Arq Neuropsiquiatr. 1998;58(Suppl 1):205.
38. Bianchin MM, Velasco TR, Wichert-Ana L, Alexandre V Jr, Terra-Bustamante VC, Inuzuka LM, et al. In endemic areas, neurocysticercosis is highly prevalent in patients with mesial temporal lobe epilepsy, but it is not a risk factor for poor surgical outcome or post-surgical cognitive decline. Epilepsia. 2005;46(Suppl 8):236.
39. Chimelli L, Lovalho AF, Takayanagui OM. Neurocysticercosis: contribution of autopsies in the consolidation of mandatory notification in Ribeirao Preto-SP, Brazil. Arq Neuropsiquiatr. 1998;56(3B):577-584.
40. da Silva AV, Martins HH, Marques CM, Yacubian EM, Sakamoto AC, Carrete H Jr, et al. Neurocysticercosis and microscopic hippocampal dysplasia in a patient with refractory mesial temporal lobe epilepsy. Arq Neuropsiquiatr. 2006;64(2A):309-313.
41. Singla M, Singh P, Kaushal S, Bansal R, Singh G. Hippocampal sclerosis in association with neurocysticercosis. Epileptic Disord. 2007;9(3):292-299.
42. Velasco TR, Zanello PA, Dalmagro CL, Araújo D Jr, Santos AC, Bianchin MM, et al. Calcified cysticercotic lesions and intractable epilepsy: a cross sectional study of 512 patients. J Neurol Neurosurg Psychiatry. 2006;77(4):485-488.
43. Oliveira M, Castro L, Martin M. Neurocysticercosis with calcified lesions and mesial temporal sclerosis: fortuitous association or possible etiologic role. Epilepsia. 2009;50(Suppl 11):38-39.
44. Bianchin MM, Velasco TR, Araujo D Jr, Alexandre V Jr, Wichert-Ana L, Terra-Bustamante V, et al. Clinical and electrophysiological differences between mesial temporal lobe epilepsy and mesial temporal lobe epilepsy plus neurocysticercosis. Epilepsia. 2006;47(Suppl 4):244-245.
45. Bianchin MM, Velasco TR, Araujo D Jr, Wichert-Ana L, Alexandre V Jr, Terra-Bustamante V, et al. Chronic neurocisticercosis is anatomically related with hippocampal sclerosis in refractory mesial temporal lobe epilepsy plus neurocysticercosis. Epilepsia. 2008;49:487.
46. Rangel R, Torres B, Del Bruto O, Sotelo J. Cysticercotic encephalitis: a severe form in young females. Am J Trop Med Hyg. 1987;36(2):387-392.
47. Chen L, Shaw S, Kim P, Heck C, Kalayjian L, Ko D, et al. Drug-resistant epilepsy, neurocysticercosis and mesial temporal sclerosis: variations on the theme of dual pathology. Epilepsy Curr. 2010;11(Suppl 1):287-288.
48. Bianchin MM, Velasco TR, Takayanagui OM, Sakamoto AC. Neurocysticercosis, mesial temporal lobe epilepsy, and hippocampal sclerosis: an association largely ignored. Lancet Neurol. 2006;5(1):20-21.
49. Bianchin MM, Dal Pizzol A, Scotta Cabral L, Martin KC, de Mello Rieder CR, Ciampi de Andrade D, et al. Cognitive impairment and dementia in neurocysticercosis: a crosssectional controlled study. Neurology. 2010;75(11):1028-1029.
50. Morales-Montor J, Arrieta I, Del Castillo LI, RodgjiguezDorantes M, Cerbón MA, Larralde C. Remote sensing of intraperitoneal parasitism by the host's brain: regional changes of c-fos gene expression in the brain of feminized cysticercotic male mice. Parasitology. 2004;128(Pt 3):343-351.
51. Bianchin MM, Velasco TR, Wichert-Ana L, Takayanagui OM, Leite JP. Sakamoto AC. How frequent is the association of neurocysticercosis and mesial temporal lobe epilepsy with hippocampal sclerosis? Epilepsia. 2010;51(11):2359-2360.